From: Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden
Remission
Mild
Moderate to severe
Surgery
2-week cost of resource use
€26
€69
€108
€7123
2-week productivity cost
€79
€281
€374
€1326